“I’ve tried everything, but nothing’s ever worked?” Sound familiar? How many times have you tried a new diet, thinking, ”This is the one that’s finally going to stick,” only to end up disappointed and hungry? What you need is a personal dietitian or nutritionist. Can’t afford one, or maybe you’d just rather spend that cash on… Read More »
Breadcrumb Trail Links Health and Wellness ‘We believe every Canadian who needs a guide dog should have that opportunity — at no cost,’ says the president of the CNIB Guide Dogs program Author of the article: Zeenya Shah Beth Deer poses with her guide dog Patronus trained by Guide Dogs for the Blind Photo by… Read More »
Oxford, UK and Pasadena, California, 29 January 2021 – Rockley Photonics, a leading integrated optics solutions provider, today announced that it has closed an additional $ 65m round of growth capital from both new private funds and follow-on existing investor Morningside Ventures. To date, Rockley has raised over $ 290m of financing to develop its… Read More »
FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain Print this page ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults… Read More »
FDA Approves Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy Print this page DUBLIN, July 22, 2020 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution on July 21, 2020 for the treatment of… Read More »
Markets have in recent weeks applauded the monumental efforts taken by Congress and the Federal Reserve to insulate the U.S. economy from the impact the coronavirus. But to traders across Wall Street, a vaccine, or at least an effective therapy, remains the No. 1 focus for the market to have a shot at clawing back… Read More »